Perioperative Treatment Strategies for Advanced Melanoma and Non-Melanoma Skin Cancers

Document Type

Journal Article

Publication Date

10-6-2025

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2025.09.098

Keywords

cutaneous oncology; dermatologic surgery; immunotherapy; neoadjuvant; perioperative

Abstract

Perioperative therapies, including neoadjuvant and neoadjuvant plus adjuvant, are developing and promising approaches to improve management of cutaneous malignancies. This review summarizes key studies of perioperative therapies to guide clinical practice in treatment of melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. The clinical trials and real-world studies reviewed routinely demonstrated that perioperative strategies, especially with immune checkpoint inhibitors, yielded high pathological response rates, improved survival, reduced treatment side effects, and decreased surgical morbidity. Moreover, perioperative therapies could enable treatment step down and even avoidance of surgery altogether.

Department

Dermatology

Share

COinS